Publisher
Springer International Publishing
Reference56 articles.
1. Grant CS, Hay ID, Gough IR, Bergstrahl EJ, Goellner JR, McConahey WM. Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important? Surgery. 1988;104(6):954–62.
2. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994;97(5):418–28. https://doi.org/10.1016/0002-9343(94)90321-2. Erratum in: Am J Med 1995 Feb;98(2):215
3. Stokkel MP, Duchateau CS, Dragoiescu C. The value of FDG-PET in the follow-up of differentiated thyroid cancer: a review of the literature. Q J Nucl Med Mol Imaging. 2006;50(1):78–87.
4. Lamartina L, Handkiewicz-Junak D. Follow-up of low risk thyroid cancer patients: can we stop follow-up after 5 years of complete remission? Eur J Endocrinol. 2020;182(5):D1–D16. https://doi.org/10.1530/EJE-19-0960.
5. Rivera-Robledo CG, Velázquez-Fernández D, Pantoja JP, Sierra M, Pérez-Enriquez B, Rivera-Moscoso R, Chapa M, Herrera MF. Recurrent papillary thyroid carcinoma to the cervical lymph nodes: outcomes of compartment-oriented lymph node resection. World J Surg. 2019;43(11):2842–9. https://doi.org/10.1007/s00268-019-05094-9.